Patrick J. McEnany - 20 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
20 Aug 2021
Net transactions value
-$139,581
Form type
4
Filing time
24 Aug 2021, 17:01:05 UTC
Previous filing
17 Aug 2021
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $249,600 +80,000 +1.7% $3.12* 4,928,304 20 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $298,860 -54,161 -1.1% $5.52 4,874,143 20 Aug 2021 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $374,400 +120,000 +2.5% $3.12* 4,994,143 23 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $464,721 -82,617 -1.7% $5.62 4,911,526 23 Aug 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -80,000 -2.3% $0.000000 3,371,667 20 Aug 2021 Common Stock 80,000 $3.12 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -120,000 -3.6% $0.000000 3,251,667 23 Aug 2021 Common Stock 120,000 $3.12 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Shares were sold in various lots from $5.455 to $5.601 per share. The listed sale price represents a weighted average price for the shares sold.
F3 Shares were sold in various lots from $5.59 to $5.675 per share. The listed sale price represents a weighted average price for the shares sold.
F4 Options vested in three annual tranches beginning on August 28, 2015.